From the bulletin: Compounded drugs containing BPC-157 may pose risk for immunogenicity for certain routes of administration and may have complexities with regard to peptide-related impurities and active pharmaceutical ingredient (API) characterization
Those are useful, but there are serious limitations regarding how benefits to animals can be translated to benefits to people
Has delirium or cognitive impairment
If a multi-dose vial is opened, discard per protocol to avoid contamination
High doses too frequently may lead to rare side effects like low potassium or vascular stress
Common experiences include: Injection site reactions: Redness, minor swelling, tenderness (resolves within hours) Transient fatigue: Mild tiredness during first 1 to 2 weeks, especially with TB-500 Headaches: Occasional mild headaches, typically in early use Vivid dreams: Some users report more memorable or intense dreams Temporary water retention: Minor and resolves with continued use Serious adverse events with healing peptides remain rare in documented use